Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - SBIR
 More »

  • New England Biolabs Looks Past Enzymes
    ... analysis-the purpose of a $640,000 Phase 2 SBIR grant the company won last November. The award adds to more than $1.1 million of SBIR funds awarded for the research since 2009. Dr. ...
    3-15-2013
  • Replicating Human Organ Biology In Vitro
    ... Wamhoff. Human Response Database In 2011, HemoShear was awarded a $4.3 million SBIR grant from the National Heart, Lung, and Blood Institute and has partnered with Expression ...
    2-15-2013
  • Lung Cancer Blood Test Could Be Epic Development
    Epic Sciences received a phase II contract from the SBIR program supported by the National ... Epic will use the SBIR funds to further develop and clinically validate a new diagnostic ...
    1-24-2013
  • SBIR Thinks Smaller
    Innovation Research (SBIR) program, as new rules take effect that are designed to draw more small businesses in biopharma and other technologies to SBIR and its companion Small ...
    1-22-2013
  • NCI Grants MabVax $150K for Neuroblastoma Vaccine
    MabVax Therapeutics received an SBIR grant from the NCI. The initial grant award of ... the firm received a $1.8 million phase 2 SBIR grant to support a Phase II trial ...
    12-18-2012
  • NIDA Refocuses on Translational, Genetic Medicine
    Small Business Innovation Research (SBIR) and Small Business Technology ... formal "omnibus" solicitation available at http://grants.nih.gov/grants/funding/sbir.htm . ...
    12-6-2012
  • Alzheimer's Disease Research Gets More Funds
    The NIH, through the Office of the Director and the National Center for Advancing Translational Sciences, awarded Factor Bioscience two Small Business Innovation Research (SBIR) ...
    11-13-2012
  • More Funds for Epigenetic Research
    (SBIR) grant to expand its research and product development of enzymatic tools for epigenetic analysis. This latest grant adds to the more than $1.1 million of SBIR funds ...
    11-8-2012
  • Grant Won to Evaluate Glucose Uptake Inhibitor in Brain Cancer
    I Small Business Innovation Research (SBIR) grant from the National Cancer Institute ... Advanced Cancer Therapeutics (ACT) won a $158,000 Phase I SBIR grant from the NCI to ...
    10-11-2012
  • Monday's News in a Nutshell
    Cellerant Therapeutics won a $1,683,503 Phase I Small Business Innovation Research (SBIR) contract and a Phase II option from the NCI to support development of the firm's human ...
    10-9-2012
  • Grant Award for Benchtop Nucleic Acid Extraction Platform
    The grant award comes less than a month after Akonni confirmed winning a a $498,780 Phase 2 SBIR Grant from the National Science Foundation to support continued development of its ...
    10-2-2012
  • Funds Won for C. difficile-Targeted Antibiotic
    AvidBiotics won a two year, $600,000 Small Business Innovation Research (SBIR) grant from ... W. Martin, M.D., on award of the latest SBIR grant. "Traditional antibiotics cannot be ...
    10-1-2012
  • SBIR Grant for Multifaceted Malaria Vaccine
    Protein Potential won three Phase I Small Business Innovation Research (SBIR) NIH grants ... Development of the P. vivax vaccine is being supported by a $3 million SBIR grant from ...
    9-26-2012
  • GenVec Slashes Workforce by 30%
    GenVec won an approximately $590,000 Phase I SBIR grant from the NIAID in May to support ... building on research initiated under an SBIR grant in 2009. Biopharma GenVec is cutting ...
    9-25-2012
  • Firms Partner on Dual-Vaccine Malaria Program
    Innovation Research (SBIR) grant to develop a dual-vaccine platform against malaria. ... I Small Business Innovation Research (SBIR) grant to develop a dual vaccine platform ...
    9-19-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll